Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Colorectal Neoplasms

  Free Subscription


Articles published in Gut

Retrieve available abstracts of 91 articles:
HTML format
Text format



Single Articles


    July 2018
  1. BAKER AM, Cross W, Curtius K, Al Bakir I, et al
    Evolutionary history of human colitis-associated colorectal cancer.
    Gut. 2018 Jul 10. pii: gutjnl-2018-316191. doi: 10.1136/gutjnl-2018-316191.
    PubMed     Text format     Abstract available


    June 2018
  2. KOMIYA Y, Shimomura Y, Higurashi T, Sugi Y, et al
    Patients with colorectal cancer have identical strains of Fusobacterium nucleatum in their colorectal cancer and oral cavity.
    Gut. 2018 Jun 22. pii: gutjnl-2018-316661. doi: 10.1136/gutjnl-2018-316661.
    PubMed     Text format    


  3. WIETEN E, Schreuders EH, Grobbee EJ, Nieboer D, et al
    Incidence of faecal occult blood test interval cancers in population-based colorectal cancer screening: a systematic review and meta-analysis.
    Gut. 2018 Jun 22. pii: gutjnl-2017-315340. doi: 10.1136/gutjnl-2017-315340.
    PubMed     Text format     Abstract available


  4. NIEUWENBURG SAV, Vuik FER, Kruip MJHA, Kuipers EJ, et al
    Effect of anticoagulants and NSAIDs on accuracy of faecal immunochemical tests (FITs) in colorectal cancer screening: a systematic review and meta-analysis.
    Gut. 2018 Jun 5. pii: gutjnl-2018-316344. doi: 10.1136/gutjnl-2018-316344.
    PubMed     Text format     Abstract available


    May 2018
  5. GLUCK N, Half EE, Bieber V, Schwartz D, et al
    Novel prep-less X-ray imaging capsule for colon cancer screening: a feasibility study.
    Gut. 2018 May 21. pii: gutjnl-2018-316127. doi: 10.1136/gutjnl-2018-316127.
    PubMed     Text format    


  6. BARENDSE RM, Musters GD, de Graaf EJR, van den Broek FJC, et al
    Randomised controlled trial of transanal endoscopic microsurgery versus endoscopic mucosal resection for large rectal adenomas (TREND Study).
    Gut. 2018;67:837-846.
    PubMed     Text format     Abstract available


    April 2018
  7. SMITH T, Muller DC, Moons KGM, Cross AJ, et al
    Comparison of prognostic models to predict the occurrence of colorectal cancer in asymptomatic individuals: a systematic literature review and external validation in the EPIC and UK Biobank prospective cohort studies.
    Gut. 2018 Apr 3. pii: gutjnl-2017-315730. doi: 10.1136/gutjnl-2017-315730.
    PubMed     Text format     Abstract available


  8. CAO Y, Wu K, Mehta R, Drew DA, et al
    Long-term use of antibiotics and risk of colorectal adenoma.
    Gut. 2018;67:672-678.
    PubMed     Text format     Abstract available


  9. MOUSSATA D, Allez M, Cazals-Hatem D, Treton X, et al
    Are random biopsies still useful for the detection of neoplasia in patients with IBD undergoing surveillance colonoscopy with chromoendoscopy?
    Gut. 2018;67:616-624.
    PubMed     Text format     Abstract available


  10. BATTERSBY NJ, Bouliotis G, Emmertsen KJ, Juul T, et al
    Development and external validation of a nomogram and online tool to predict bowel dysfunction following restorative rectal cancer resection: the POLARS score.
    Gut. 2018;67:688-696.
    PubMed     Text format     Abstract available


    March 2018
  11. JOO JE, Jayasekara H, Wong EM, Clendenning M, et al
    Assessing the ProMCol classifier as a prognostic marker for non-metastatic colorectal cancer within the Melbourne Collaborative Cohort Study.
    Gut. 2018 Mar 24. pii: gutjnl-2018-316122. doi: 10.1136/gutjnl-2018-316122.
    PubMed     Text format    


  12. RIGTER LS, Snaebjornsson P, Rosenberg EH, Atmodimedjo PN, et al
    Double somatic mutations in mismatch repair genes are frequent in colorectal cancer after Hodgkin's lymphoma treatment.
    Gut. 2018;67:447-455.
    PubMed     Text format     Abstract available


  13. DAVENPORT JR, Su T, Zhao Z, Coleman HG, et al
    Modifiable lifestyle factors associated with risk of sessile serrated polyps, conventional adenomas and hyperplastic polyps.
    Gut. 2018;67:456-465.
    PubMed     Text format     Abstract available


    February 2018
  14. SUNDKVIST A, Myte R, Palmqvist R, Harlid S, et al
    Plasma ghrelin is probably not a useful biomarker for risk prediction or early detection of colorectal cancer.
    Gut. 2018 Feb 28. pii: gutjnl-2018-316110. doi: 10.1136/gutjnl-2018-316110.
    PubMed     Text format    


  15. CREMONESI E, Governa V, Garzon JFG, Mele V, et al
    Gut microbiota modulate T cell trafficking into human colorectal cancer.
    Gut. 2018 Feb 6. pii: gutjnl-2016-313498. doi: 10.1136/gutjnl-2016-313498.
    PubMed     Text format     Abstract available


  16. OVERWATER A, Kessels K, Elias SG, Backes Y, et al
    Endoscopic resection of high-risk T1 colorectal carcinoma prior to surgical resection has no adverse effect on long-term outcomes.
    Gut. 2018;67:284-290.
    PubMed     Text format     Abstract available


  17. RICHARDS CH, Ventham NT, Mansouri D, Wilson M, et al
    An evidence-based treatment algorithm for colorectal polyp cancers: results from the Scottish Screen-detected Polyp Cancer Study (SSPoCS).
    Gut. 2018;67:299-306.
    PubMed     Text format     Abstract available


    January 2018
  18. WILLIAMS DS, Mouradov D, Jorissen RN, Newman MR, et al
    Lymphocytic response to tumour and deficient DNA mismatch repair identify subtypes of stage II/III colorectal cancer associated with patient outcomes.
    Gut. 2018 Jan 30. pii: gutjnl-2017-315664. doi: 10.1136/gutjnl-2017-315664.
    PubMed     Text format     Abstract available


  19. DE ARCANGELIS A, Chamaillard M, Simon-Assmann P, Labouesse M, et al
    Integrin a6 loss promotes colitis-associated colorectal cancer. Response to: "Integrin a6 variants and colorectal cancer" by Beaulieu JF.
    Gut. 2018 Jan 3. pii: gutjnl-2017-315727. doi: 10.1136/gutjnl-2017-315727.
    PubMed     Text format    


  20. BACKES Y, Schwartz MP, Ter Borg F, Wolfhagen FHJ, et al
    Multicentre prospective evaluation of real-time optical diagnosis of T1 colorectal cancer in large non-pedunculated colorectal polyps using narrow band imaging (the OPTICAL study).
    Gut. 2018 Jan 3. pii: gutjnl-2017-314723. doi: 10.1136/gutjnl-2017-314723.
    PubMed     Text format     Abstract available


  21. LAWLER M, Alsina D, Adams RA, Anderson AS, et al
    Critical research gaps and recommendations to inform research prioritisation for more effective prevention and improved outcomes in colorectal cancer.
    Gut. 2018;67:179-193.
    PubMed     Text format     Abstract available


  22. CARBALLAL S, Maisterra S, Lopez-Serrano A, Gimeno-Garcia AZ, et al
    Real-life chromoendoscopy for neoplasia detection and characterisation in long-standing IBD.
    Gut. 2018;67:70-78.
    PubMed     Text format     Abstract available


    December 2017
  23. DEMING DA
    Tailoring the colorectal cancer disease assessment to the treatment strategy.
    Gut. 2017 Dec 21. pii: gutjnl-2017-315394. doi: 10.1136/gutjnl-2017-315394.
    PubMed     Text format    


  24. SIEVERS CK, Zou LS, Pickhardt PJ, Matkowskyj KA, et al
    Subclonal diversity arises early even in small colorectal tumours and contributes to differential growth fates.
    Gut. 2017;66:2132-2140.
    PubMed     Text format     Abstract available


    November 2017
  25. WAN L, Yu W, Shen E, Sun W, et al
    SRSF6-regulated alternative splicing that promotes tumour progression offers a therapy target for colorectal cancer.
    Gut. 2017 Nov 7. pii: gutjnl-2017-314983. doi: 10.1136/gutjnl-2017-314983.
    PubMed     Text format     Abstract available


  26. GUNDERT M, Edelmann D, Benner A, Jansen L, et al
    Genome-wide DNA methylation analysis reveals a prognostic classifier for non-metastatic colorectal cancer (ProMCol classifier).
    Gut. 2017 Nov 3. pii: gutjnl-2017-314711. doi: 10.1136/gutjnl-2017-314711.
    PubMed     Text format     Abstract available


  27. ZORZI M, Hassan C, Capodaglio G, Fedato C, et al
    Long-term performance of colorectal cancer screening programmes based on the faecal immunochemical test.
    Gut. 2017 Nov 3. pii: gutjnl-2017-314753. doi: 10.1136/gutjnl-2017-314753.
    PubMed     Text format     Abstract available


    October 2017
  28. MAZARD T, Boonsirikamchai P, Overman MJ, Asran MA, et al
    Comparison of early radiological predictors of outcome in patients with colorectal cancer with unresectable hepatic metastases treated with bevacizumab.
    Gut. 2017 Oct 30. pii: gutjnl-2017-313786. doi: 10.1136/gutjnl-2017-313786.
    PubMed     Text format     Abstract available


  29. BEAULIEU JF
    Integrin alpha6 variants and colorectal cancer.
    Gut. 2017 Oct 28. pii: gutjnl-2017-315415. doi: 10.1136/gutjnl-2017-315415.
    PubMed     Text format    


  30. SCHRAMM C, Janhsen K, Demir M, Nierhoff D, et al
    Serrated polyposis syndrome may go undiagnosed even in structured colorectal cancer screening programmes performed by endoscopists with otherwise good quality indices.
    Gut. 2017 Oct 21. pii: gutjnl-2017-315321. doi: 10.1136/gutjnl-2017-315321.
    PubMed     Text format    


  31. FLEMER B, Warren RD, Barrett MP, Cisek K, et al
    The oral microbiota in colorectal cancer is distinctive and predictive.
    Gut. 2017 Oct 7. pii: gutjnl-2017-314814. doi: 10.1136/gutjnl-2017-314814.
    PubMed     Text format     Abstract available


  32. BARAULT L, Amatu A, Siravegna G, Ponzetti A, et al
    Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer.
    Gut. 2017 Oct 5. pii: gutjnl-2016-313372. doi: 10.1136/gutjnl-2016-313372.
    PubMed     Text format     Abstract available


    August 2017
  33. DIGBY J, Fraser CG, Carey FA, Steele RJC, et al
    Can the performance of a quantitative FIT-based colorectal cancer screening programme be enhanced by lowering the threshold and increasing the interval?
    Gut. 2017 Aug 24. pii: gutjnl-2017-314862. doi: 10.1136/gutjnl-2017-314862.
    PubMed     Text format    


  34. KHAN K, Rata M, Cunningham D, Koh DM, et al
    Functional imaging and circulating biomarkers of response to regorafenib in treatment-refractory metastatic colorectal cancer patients in a prospective phase II study.
    Gut. 2017 Aug 8. pii: gutjnl-2017-314178. doi: 10.1136/gutjnl-2017-314178.
    PubMed     Text format     Abstract available


  35. ROBERTS SK
    Train-the-trainer education and colonoscopy quality indicators: where to now?
    Gut. 2017;66:1533-1534.
    PubMed     Text format    


    July 2017
  36. YANG W, Liu L, Masugi Y, Qian ZR, et al
    Calcium intake and risk of colorectal cancer according to expression status of calcium-sensing receptor (CASR).
    Gut. 2017 Jul 4. pii: gutjnl-2017-314163. doi: 10.1136/gutjnl-2017-314163.
    PubMed     Text format     Abstract available


  37. EAST JE, Atkin WS, Bateman AC, Clark SK, et al
    British Society of Gastroenterology position statement on serrated polyps in the colon and rectum.
    Gut. 2017;66:1181-1196.
    PubMed     Text format     Abstract available


    June 2017
  38. HAWINKELS LJ, Hardwick JC
    Putting the Wnt up colon cancer.
    Gut. 2017;66:983-984.
    PubMed     Text format    


  39. ADAMS LA, Anstee QM, Tilg H, Targher G, et al
    Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases.
    Gut. 2017;66:1138-1153.
    PubMed     Text format     Abstract available


  40. BUCHANAN DD, Clendenning M, Zhuoer L, Stewart JR, et al
    Lack of evidence for germline RNF43 mutations in patients with serrated polyposis syndrome from a large multinational study.
    Gut. 2017;66:1170-1172.
    PubMed     Text format    


    May 2017
  41. OMAR AL-HASSI H, Ng O, Brookes M
    Tumour-associated and non-tumour-associated microbiota in colorectal cancer.
    Gut. 2017 May 4. pii: gutjnl-2017-314219. doi: 10.1136/gutjnl-2017-314219.
    PubMed     Text format    


  42. PARANG B, Kaz AM, Barrett CW, Short SP, et al
    BVES regulates c-Myc stability via PP2A and suppresses colitis-induced tumourigenesis.
    Gut. 2017;66:852-862.
    PubMed     Text format     Abstract available


  43. REES CJ, Rajasekhar PT, Wilson A, Close H, et al
    Narrow band imaging optical diagnosis of small colorectal polyps in routine clinical practice: the Detect Inspect Characterise Resect and Discard 2 (DISCARD 2) study.
    Gut. 2017;66:887-895.
    PubMed     Text format     Abstract available


    April 2017
  44. MANIC G, Signore M, Sistigu A, Russo G, et al
    CHK1-targeted therapy to deplete DNA replication-stressed, p53-deficient, hyperdiploid colorectal cancer stem cells.
    Gut. 2017 Apr 7. pii: gutjnl-2016-312623. doi: 10.1136/gutjnl-2016-312623.
    PubMed     Text format     Abstract available


  45. DE BARRIOS O, Gyorffy B, Fernandez-Acenero MJ, Sanchez-Tillo E, et al
    ZEB1-induced tumourigenesis requires senescence inhibition via activation of DKK1/mutant p53/Mdm2/CtBP and repression of macroH2A1.
    Gut. 2017;66:666-682.
    PubMed     Text format     Abstract available


  46. FLEMER B, Lynch DB, Brown JM, Jeffery IB, et al
    Tumour-associated and non-tumour-associated microbiota in colorectal cancer.
    Gut. 2017;66:633-643.
    PubMed     Text format     Abstract available


  47. ARNOLD M, Sierra MS, Laversanne M, Soerjomataram I, et al
    Global patterns and trends in colorectal cancer incidence and mortality.
    Gut. 2017;66:683-691.
    PubMed     Text format     Abstract available


  48. PELLISE M, Burgess NG, Tutticci N, Hourigan LF, et al
    Endoscopic mucosal resection for large serrated lesions in comparison with adenomas: a prospective multicentre study of 2000 lesions.
    Gut. 2017;66:644-653.
    PubMed     Text format     Abstract available


  49. AMICARELLA F, Muraro MG, Hirt C, Cremonesi E, et al
    Dual role of tumour-infiltrating T helper 17 cells in human colorectal cancer.
    Gut. 2017;66:692-704.
    PubMed     Text format     Abstract available


  50. HUR K, Toiyama Y, Okugawa Y, Ide S, et al
    Circulating microRNA-203 predicts prognosis and metastasis in human colorectal cancer.
    Gut. 2017;66:654-665.
    PubMed     Text format     Abstract available


    March 2017
  51. SAKUMA K, Sasaki E, Kimura K, Komori K, et al
    HNRNPLL, a newly identified colorectal cancer metastasis suppressor, modulates alternative splicing of CD44 during epithelial-mesenchymal transition.
    Gut. 2017 Mar 30. pii: gutjnl-2016-312927. doi: 10.1136/gutjnl-2016-312927.
    PubMed     Text format     Abstract available


  52. SHAH MS, DeSantis TZ, Weinmaier T, McMurdie PJ, et al
    Leveraging sequence-based faecal microbial community survey data to identify a composite biomarker for colorectal cancer.
    Gut. 2017 Mar 24. pii: gutjnl-2016-313189. doi: 10.1136/gutjnl-2016-313189.
    PubMed     Text format     Abstract available


  53. KINROSS J
    Race-specific differences in mucosal sulfidogenic bacteria modify colon cancer risk.
    Gut. 2017 Mar 20. pii: gutjnl-2017-313989. doi: 10.1136/gutjnl-2017-313989.
    PubMed     Text format    


  54. MENNONNA D, Maccalli C, Romano MC, Garavaglia C, et al
    T cell neoepitope discovery in colorectal cancer by high throughput profiling of somatic mutations in expressed genes.
    Gut. 2017;66:454-463.
    PubMed     Text format     Abstract available


  55. VAN DOORN SC, van der Vlugt M, Depla A, Wientjes CA, et al
    Adenoma detection with Endocuff colonoscopy versus conventional colonoscopy: a multicentre randomised controlled trial.
    Gut. 2017;66:438-445.
    PubMed     Text format     Abstract available


  56. GUPTA S, Jacobs ET, Baron JA, Lieberman DA, et al
    Risk stratification of individuals with low-risk colorectal adenomas using clinical characteristics: a pooled analysis.
    Gut. 2017;66:446-453.
    PubMed     Text format     Abstract available


  57. MOLLER P, Seppala T, Bernstein I, Holinski-Feder E, et al
    Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database.
    Gut. 2017;66:464-472.
    PubMed     Text format     Abstract available


    February 2017
  58. SIRAJ AK, Masoodi T, Bu R, Pratheeshkumar P, et al
    MED12 is recurrently mutated in Middle Eastern colorectal cancer.
    Gut. 2017 Feb 9. pii: gutjnl-2016-313334. doi: 10.1136/gutjnl-2016-313334.
    PubMed     Text format     Abstract available


  59. YAZICI C, Wolf PG, Kim H, Cross TL, et al
    Race-dependent association of sulfidogenic bacteria with colorectal cancer.
    Gut. 2017 Feb 2. pii: gutjnl-2016-313321. doi: 10.1136/gutjnl-2016-313321.
    PubMed     Text format     Abstract available


  60. RADAELLI F, Paggi S, Hassan C, Senore C, et al
    Split-dose preparation for colonoscopy increases adenoma detection rate: a randomised controlled trial in an organised screening programme.
    Gut. 2017;66:270-277.
    PubMed     Text format     Abstract available


  61. IJSPEERT JE, Rana SA, Atkinson NS, van Herwaarden YJ, et al
    Clinical risk factors of colorectal cancer in patients with serrated polyposis syndrome: a multicentre cohort analysis.
    Gut. 2017;66:278-284.
    PubMed     Text format     Abstract available


  62. CHIU SY, Chuang SL, Chen SL, Yen AM, et al
    Faecal haemoglobin concentration influences risk prediction of interval cancers resulting from inadequate colonoscopy quality: analysis of the Taiwanese Nationwide Colorectal Cancer Screening Program.
    Gut. 2017;66:293-300.
    PubMed     Text format     Abstract available


  63. ROY HK, Turzhitsky V, Wali R, Radosevich AJ, et al
    Spectral biomarkers for chemoprevention of colonic neoplasia: a placebo-controlled double-blinded trial with aspirin.
    Gut. 2017;66:285-292.
    PubMed     Text format     Abstract available


    January 2017
  64. TULCHINSKY E
    Colorectal cancer cells use the negative feedback regulators of WNT signalling to activate epithelial-mesenchymal transition pathways.
    Gut. 2017 Jan 12. pii: gutjnl-2016-313185. doi: 10.1136/gutjnl-2016-313185.
    PubMed     Text format    


  65. DE KLERK CM, Gupta S, Dekker E, Essink-Bot ML, et al
    Socioeconomic and ethnic inequities within organised colorectal cancer screening programmes worldwide.
    Gut. 2017 Jan 10. pii: gutjnl-2016-313311. doi: 10.1136/gutjnl-2016-313311.
    PubMed     Text format     Abstract available


  66. BETTINGTON M, Walker N, Rosty C, Brown I, et al
    Clinicopathological and molecular features of sessile serrated adenomas with dysplasia or carcinoma.
    Gut. 2017;66:97-106.
    PubMed     Text format     Abstract available


  67. OKUGAWA Y, Toiyama Y, Toden S, Mitoma H, et al
    Clinical significance of SNORA42 as an oncogene and a prognostic biomarker in colorectal cancer.
    Gut. 2017;66:107-117.
    PubMed     Text format     Abstract available


  68. YU J, Feng Q, Wong SH, Zhang D, et al
    Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer.
    Gut. 2017;66:70-78.
    PubMed     Text format     Abstract available


  69. KAPIDZIC A, van Roon AH, van Leerdam ME, van Vuuren AJ, et al
    Attendance and diagnostic yield of repeated two-sample faecal immunochemical test screening for colorectal cancer.
    Gut. 2017;66:118-123.
    PubMed     Text format     Abstract available


    December 2016
  70. PASSAMONTI B, Malaspina M, Fraser CG, Tintori B, et al
    A comparative effectiveness trial of two faecal immunochemical tests for haemoglobin (FIT). Assessment of test performance and adherence in a single round of a population-based screening programme for colorectal cancer.
    Gut. 2016 Dec 14. pii: gutjnl-2016-312716. doi: 10.1136/gutjnl-2016-312716.
    PubMed     Text format     Abstract available


    November 2016
  71. COLUSSI D, Zagari RM, Morini B, Fabbri M, et al
    Prevalence of serrated polyposis syndrome in an FIT-based colorectal cancer screening cohort in Italy.
    Gut. 2016 Nov 15. pii: gutjnl-2016-313063. doi: 10.1136/gutjnl-2016-313063.
    PubMed     Text format    


  72. HUANG Y, Zhou J, Luo S, Wang Y, et al
    Identification of a fluorescent small-molecule enhancer for therapeutic autophagy in colorectal cancer by targeting mitochondrial protein translocase TIM44.
    Gut. 2016 Nov 14. pii: gutjnl-2016-311909. doi: 10.1136/gutjnl-2016-311909.
    PubMed     Text format     Abstract available


  73. RHO JH, Ladd JJ, Li CI, Potter JD, et al
    Protein and glycomic plasma markers for early detection of adenoma and colon cancer.
    Gut. 2016 Nov 7. pii: gutjnl-2016-312794. doi: 10.1136/gutjnl-2016-312794.
    PubMed     Text format     Abstract available


    October 2016
  74. NULSEN B, Lewis B
    Response to: 'Full-spectrum (FUSE) versus standard forward-viewing colonoscopy in an organised colorectal cancer screening programme' by Hassan et al.
    Gut. 2016 Oct 24. pii: gutjnl-2016-313117. doi: 10.1136/gutjnl-2016-313117.
    PubMed     Text format    


  75. DOWNING A, Morris EJ, Corrigan N, Sebag-Montefiore D, et al
    High hospital research participation and improved colorectal cancer survival outcomes: a population-based study.
    Gut. 2016 Oct 19. pii: gutjnl-2015-311308. doi: 10.1136/gutjnl-2015-311308.
    PubMed     Text format     Abstract available


  76. DOUBENI CA, Corley DA, Quinn VP, Jensen CD, et al
    Effectiveness of screening colonoscopy in reducing the risk of death from right and left colon cancer: a large community-based study.
    Gut. 2016 Oct 12. pii: gutjnl-2016-312712. doi: 10.1136/gutjnl-2016-312712.
    PubMed     Text format     Abstract available


    September 2016
  77. BOROVSKI T, Vellinga TT, Laoukili J, Santo EE, et al
    Inhibition of RAF1 kinase activity restores apicobasal polarity and impairs tumour growth in human colorectal cancer.
    Gut. 2016 Sep 26. pii: gutjnl-2016-311547. doi: 10.1136/gutjnl-2016-311547.
    PubMed     Text format     Abstract available


  78. LINDNER AU, Salvucci M, Morgan C, Monsefi N, et al
    BCL-2 system analysis identifies high-risk colorectal cancer patients.
    Gut. 2016 Sep 23. pii: gutjnl-2016-312287. doi: 10.1136/gutjnl-2016-312287.
    PubMed     Text format     Abstract available


    August 2016
  79. GROBBEE EJ, van der Vlugt M, van Vuuren AJ, Stroobants AK, et al
    A randomised comparison of two faecal immunochemical tests in population-based colorectal cancer screening.
    Gut. 2016 Aug 9. pii: gutjnl-2016-311819. doi: 10.1136/gutjnl-2016-311819.
    PubMed     Text format     Abstract available


  80. HASSAN C, Senore C, Radaelli F, De Pretis G, et al
    Full-spectrum (FUSE) versus standard forward-viewing colonoscopy in an organised colorectal cancer screening programme.
    Gut. 2016 Aug 9. pii: gutjnl-2016-311906. doi: 10.1136/gutjnl-2016-311906.
    PubMed     Text format     Abstract available


    July 2016
  81. GRILLET F, Bayet E, Villeronce O, Zappia L, et al
    Circulating tumour cells from patients with colorectal cancer have cancer stem cell hallmarks in ex vivo culture.
    Gut. 2016 Jul 25. pii: gutjnl-2016-311447. doi: 10.1136/gutjnl-2016-311447.
    PubMed     Text format     Abstract available


  82. SONG M, Zhang X, Meyerhardt JA, Giovannucci EL, et al
    Marine omega-3 polyunsaturated fatty acid intake and survival after colorectal cancer diagnosis.
    Gut. 2016 Jul 19. pii: gutjnl-2016-311990. doi: 10.1136/gutjnl-2016-311990.
    PubMed     Text format     Abstract available


  83. DE ARCANGELIS A, Hamade H, Alpy F, Normand S, et al
    Hemidesmosome integrity protects the colon against colitis and colorectal cancer.
    Gut. 2016 Jul 1. pii: gutjnl-2015-310847. doi: 10.1136/gutjnl-2015-310847.
    PubMed     Text format     Abstract available


    May 2016
  84. MASUGI Y, Nishihara R, Yang J, Mima K, et al
    Tumour CD274 (PD-L1) expression and T cells in colorectal cancer.
    Gut. 2016 May 5. pii: gutjnl-2016-311421. doi: 10.1136/gutjnl-2016-311421.
    PubMed     Text format     Abstract available


    April 2016
  85. KAMINSKI MF, Anderson J, Valori R, Kraszewska E, et al
    Leadership training to improve adenoma detection rate in screening colonoscopy: a randomised trial.
    Gut. 2016;65:616-24.
    PubMed     Text format     Abstract available


    March 2016
  86. ADAMI HO, Bretthauer M, Emilsson L, Hernan MA, et al
    The continuing uncertainty about cancer risk in inflammatory bowel disease.
    Gut. 2016 Mar 23. pii: gutjnl-2015-311003. doi: 10.1136/gutjnl-2015-311003.
    PubMed     Text format    


  87. BURGESS NG, Pellise M, Nanda KS, Hourigan LF, et al
    Clinical and endoscopic predictors of cytological dysplasia or cancer in a prospective multicentre study of large sessile serrated adenomas/polyps.
    Gut. 2016;65:437-46.
    PubMed     Text format     Abstract available


  88. FACCIORUSSO A, Ferrusquia J, Muscatiello N
    Lead time bias in estimating survival outcomes.
    Gut. 2016;65:538-9.
    PubMed     Text format    


    February 2016
  89. SONG M, Nishihara R, Wang M, Chan AT, et al
    Plasma 25-hydroxyvitamin D and colorectal cancer risk according to tumour immunity status.
    Gut. 2016;65:296-304.
    PubMed     Text format     Abstract available


  90. COUGNOUX A, Delmas J, Gibold L, Fais T, et al
    Small-molecule inhibitors prevent the genotoxic and protumoural effects induced by colibactin-producing bacteria.
    Gut. 2016;65:278-85.
    PubMed     Text format     Abstract available


  91. DORIA-ROSE VP, Levin TR, Palitz A, Conell C, et al
    Ten-year incidence of colorectal cancer following a negative screening sigmoidoscopy: an update from the Colorectal Cancer Prevention (CoCaP) programme.
    Gut. 2016;65:271-7.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: